Product Specific References | - Fisher LW, Stubbs JT 3rd, Young MF. Antisera and cDNA probes to human andcertain animal model bone matrix noncollagenous proteins. Acta Orthop ScandSuppl. 1995 Oct;266:61-5. PubMed PMID: 8553864.
- Neufeld EB, Zadrozny LM, Phillips D, Aponte A, Yu ZX, Balaban RS. Decorin and biglycan retain LDL in disease-prone valvular and aortic subendothelial intimalmatrix. Atherosclerosis. 2014 Mar;233(1):113-21.
- JWilson CG, Nishimuta JF, Levenston ME. Chondrocytes and meniscalfibrochondrocytes differentially process aggrecan during de novo extracellularmatrix assembly. Tissue Eng Part A. 2009 Jul;15(7):1513-22.
- von Marschall Z, Fisher LW. Decorin is processed by three isoforms of bonemorphogenetic protein-1 (BMP1). Biochem Biophys Res Commun. 2010 Jan15;391(3):1374-8.
- Bredrup C, Stang E, Bruland O, Palka BP, Young RD, Haavik J, Knappskog PM,Rodahl E. Decorin accumulation contributes to the stromal opacities found incongenital stromal corneal dystrophy. Invest Ophthalmol Vis Sci. 2010Nov;51(11):5578-82.
- Merrilees MJ, Ching PS, Beaumont B, Hinek A, Wight TN, Black PN. Changes inelastin, elastin binding protein and versican in alveoli in chronic obstructivepulmonary disease. Respir Res. 2008 May 18;9:41.
|